Skip to Main Content
Center for Medical Education
YSM Home

INFORMATION FOR

Adam de Havenon, MD, MSCI

Associate Professor Term
DownloadHi-Res Photo

About

Titles

Associate Professor Term

Biography

Dr. de Havenon is an Associate Professor of Neurology. After receiving his B.A. from Yale University in 2001, he received his medical degree from Brown School of Medicine in 2009 and completed internship and neurology residency at the University of Utah in 2013. He finished a vascular neurology fellowship at University of Washington in 2014 and was a faculty member at the University of Utah from 2014-2021. In late 2021, Dr. de Havenon returned to Yale. His clinical practice includes evaluating and treating acute strokes in the hospital and emergency department and providing outpatient consultation in the stroke clinic. He has a particular clinical interest in intracranial atherosclerosis, vascular cognitive impairment, and optimizing secondary stroke prevention. Dr. de Havenon has published over 150 peer-reviewed articles and his research into secondary stroke prevention and advanced neuroimaging has received funding from the National Institutes of Health, American Academy of Neurology, and American Heart Association.

Appointments

  • Neurology

    Associate Professor on Term
    Primary
    Neurology

Other Departments & Organizations

Education & Training

MSCI
University of Utah (2021)
Vascular Neurology Fellow
University of Washington (2014)
Neurology Resident
University of Utah (2013)
MD
Brown Medical School (2009)
BA
Yale University, American Studies (2001)

Research

Overview

During vascular neurology fellowship training, I discovered that I want the expertise to successfully fill the space between the basic science of stroke research and its implementation in human subjects. My long-term research goal is to bridge these fields and lead a team of basic and clinical researchers to address the most treatment-resistant diseases in vascular neurology and to provide excellent care to patients suffering from these diseases. I have consistently obtained competitive grant awards, including a K23, R01, and UG3/UH3 from NIH/NINDS. In 2021, I finished a Masters of Science in Clinical Investigation degree. I am the principal investigator of the observational trial in my K23, the multicenter BP-VISO study, and the StrokeNet study CAPTIVA-MRI. At my prior institution, I established the de Havenon Lab and mentees in my lab received a number of research awards and scholarships, including an NIH NRS training grant and an American Academy of Neurology Medical Student Research Scholarship. In 2022, we established the de Havenon lab at Yale and have been expanding its footprint. The lab's goal is to advance research that will benefit patients with stroke and to help train the next generation of cerebrovascular researchers.

Research at a Glance

Yale Co-Authors

Frequent collaborators of Adam de Havenon's published research.

Publications

2024

See All Publications

Clinical Trials

Current Trials

Clinical Care

Overview

Adam de Havenon, MD, is a vascular neurologist who primarily treats patients with stroke, but also cares for patients with vascular malformations, aneurysms, and a variety of other neurological diseases including cerebral amyloid angiopathy.

“I was always interested in the brain, and I knew in medical school that I wanted to be a neurologist,” Dr. de Havenon says. “During my general neurology residency, I was drawn to the ability to effectively treat patients with stroke, as well as the fact that stroke is such a common disease, allowing you to have an impact on many patients.” As the field evolved, he trained to be able treat complicated stroke cases.

“Even in the 10 years or so I’ve been practicing, there have been so many developments,” Dr. de Havenon says. Treatments for acute, ischemic, and hemorrhagic stroke have been evolving so rapidly that “we’re able to offer interventions to improve outcomes for patients that we couldn’t do even three years ago.”

But it’s also important for anyone who is experiencing symptoms of stroke to get to the hospital as quickly as possible so treatments can be administered, he says. People should call 9-1-1 right away if they notice sudden symptoms including numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion; trouble seeing or walking; or severe headache with no known cause.

Dr. de Havenon says his clinical work and research overlap in that he typically treats similar patients in both areas. He is especially interested in intracranial atherosclerosis, vascular cognitive impairment, and stroke in people younger than 50. “Essentially, I think of it as stroke prevention research,” he says. “What I am trying to find out is how to prevent future strokes and improve the quality of life for my patients.”

Clinical Specialties

Neurology; Stroke

Fact Sheets

See All Fact Sheets On Yale Medicine

Board Certifications

  • Vascular Neurology

    Certification Organization
    AB of Psychiatry & Neurology
    Original Certification Date
    2014

  • Neurology

    Certification Organization
    AB of Psychiatry & Neurology
    Original Certification Date
    2013

Yale Medicine News

See All News On Yale Medicine

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Get In Touch

Contacts

Email
Appointment Number
Mailing Address

Neurology

15 York St

New Haven, CT 06510

United States

Administrative Support